Palivizumab prophylaxis in respiratory syncytial virus epidemia; Neonatal intensive care unit experience

dc.contributor.authorYilmaz, Fatma Hilal
dc.contributor.authorGultekin, Nazli Dilay
dc.contributor.authorAltunhan, Huseyin
dc.date.accessioned2024-02-23T14:40:46Z
dc.date.available2024-02-23T14:40:46Z
dc.date.issued2017
dc.departmentNEÜen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.identifier.doi10.4328/JCAM.5260
dc.identifier.issn1309-0720
dc.identifier.issn1309-2014
dc.identifier.scopus2-s2.0-85032012954en_US
dc.identifier.urihttps://doi.org/10.4328/JCAM.5260
dc.identifier.urihttps://hdl.handle.net/20.500.12452/16569
dc.identifier.volume8en_US
dc.identifier.wosWOS:000435639400002en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherDerman Medical Publen_US
dc.relation.ispartofJournal Of Clinical And Analytical Medicineen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titlePalivizumab prophylaxis in respiratory syncytial virus epidemia; Neonatal intensive care unit experienceen_US
dc.typeLetteren_US

Dosyalar